Background Migration of Latin Americans to the USA, Canada and Europe has modified Chagas disease distribution, but data on imported cases and on risks of local transmission remain scarce. We assessed the prevalence and risk factors for Chagas disease, staged the disease and evaluated attitudes towards blood transfusion and organ transplant among Latin American migrants in Geneva, Switzerland. Methodology/Principal Findings This cross-sectional study included all consecutive Latin American migrants seeking medical care at a primary care facility or attending two Latino churches. After completing a questionnaire, they were screened for Chagas disease with two serological tests (Biomérieux ELISA cruzi; Biokit Bioelisa Chagas). Infected subjects underwent a complete medical work-up. Predictive factors for infection were assessed by univariate and multivariate logistic regression analysis.1012 persons (females: 83%; mean age: 37.2 [SD 11.3] years, Bolivians: 48% [n = 485]) were recruited. 96% had no residency permit. Chagas disease was diagnosed with two positive serological tests in 130 patients (12.8%; 95%CI 10.8%–14.9%), including 127 Bolivians (26.2%; 95%CI 22.3%–30.1%). All patients were in the chronic phase, including 11.3% with cardiac and 0.8% with digestive complications. Predictive factors for infection were Bolivian origin (OR 33.2; 95%CI 7.5–147.5), reported maternal infection with T. cruzi (OR 6.9; 95%CI 1.9–24.3), and age older than 35 years (OR 6.7; 95%CI 2.4–18.8). While 22 (16.9%) infected subjects had already donated blood, 24 (18.5%) and 34 (26.2%) considered donating blood and organs outside Latin America, respectively. Conclusions Chagas disease is highly prevalent among Bolivian migrants in Switzerland. Chronic cardiac and digestive complications were substantial. Screening of individuals at risk should be implemented in nonendemic countries and must include undocumented migrants.
References
[1]
Prata A (2001) Clinical and epidemiological aspects of Chagas disease. Lancet Infect Dis 1: 92–100. doi: 10.1016/S1473-3099(01)00065-2
[2]
Hotez PJ, Bottazzi ME, Franco-Paredes C, Ault SK, Periago MR (2008) The neglected tropical diseases of latin america and the Caribbean: a review of disease burden and distribution and a roadmap for control and elimination. PLoS Negl Trop Dis 2: e300. doi: 10.1371/journal.pntd.0000300
[3]
Schofield CJ, Jannin J, Salvatella R (2006) The future of Chagas disease control. Trends Parasitol 22: 583–8. doi: 10.1016/j.pt.2006.09.011
[4]
Schmunis GA (2007) Epidemiology of Chagas disease in non-endemic countries: the role of international migration. Mem Inst Oswaldo Cruz 102: Suppl 175–85. doi: 10.1590/S0074-02762007005000093
[5]
Munoz J, Gomez i Prat J, Gallego M, Gimeno F, Trevino B, et al. (2009) Clinical profile of Trypanosoma cruzi infection in a non-endemic setting: immigration and Chagas disease in Barcelona (Spain). Acta Trop 111: 51–5. doi: 10.1016/j.actatropica.2009.02.005
[6]
Lescure FX, Canestri A, Melliez H, Jauréguiberry S, Develoux M, et al. (2008) Chagas disease, France. Emerg Infect Dis 14: 644–6. doi: 10.3201/eid1404.070489
[7]
Guerri-Guttenberg RA, Grana DR, Ambrosio G, Milei J (2008) Chagas cardiomyopathy: Europe is not spared! Eur Heart J 29: 2587–91. doi: 10.1093/eurheartj/ehn424
[8]
Milei J, Guerri-Guttenberg RA, Grana DR, Storino R (2009) Prognostic impact of Chagas disease in the United States. Am Heart J 157: 22–9. doi: 10.1016/j.ahj.2008.08.024
[9]
Jackson Y, Myers C, Diana A, Marti HP, Wolff H, et al. (2009) Congenital transmission of chagas disease in latin american immigrants in Switzerland. Emerg Infect Dis 15: 601–3. doi: 10.3201/eid1504.080438
[10]
Munoz J, Coll O, Juncosa T, Verges M, del Pino M, et al. (2009) Prevalence and vertical transmission of Trypanosoma cruzi infection among pregnant Latin American women attending 2 maternity clinics in Barcelona, Spain. Clin Infect Dis 48: 1736–40. doi: 10.1086/599223
[11]
Castro E (2009) Chagas' disease: lessons from routine donation testing. Transfus Med 19: 16–23. doi: 10.1111/j.1365-3148.2009.00915.x
[12]
Schmunis GA, Rodriguez G, Coenen J, Bellorin EG, Gianella A (2008) Prevention of blood-borne diseases in Bolivia, 1993–2002. Am J Trop Med Hyg 79: 803–8.
[13]
Bern C, Montgomery SP, Herwaldt BL, Rassi A Jr, Marin Nieto JA, et al. (2007) Evaluation and treatment of chagas disease in the United States: a systematic review. JAMA 298: 2171–81. doi: 10.1001/jama.298.18.2171
[14]
de Ayala AP, Perez-Molina JA, Norman F, Lopez-Velez R (2009) Chagasic cardiomyopathy in immigrants from Latin America to Spain. Emerg Infect Dis 15: 607–8. doi: 10.3201/eid1504.080938
[15]
Piron M, Verges M, Munoz J, Casamitjana N, Sanz S, et al. (2008) Seroprevalence of Trypanosoma cruzi infection in at-risk blood donors in Catalonia (Spain). Transfusion 48: 1862–8. doi: 10.1111/j.1537-2995.2008.01789.x
[16]
Swiss federal office for migration (2009) Number of permanent foreign resident population by nationality; Available: http://www.bfm.admin.ch/etc/medialib/dat？a/migration/statistik/auslaenderstatisti？k/2008.Par.0047.File.tmp/ts8_wohnbevoelk？erung_staat_2008-12-e.pdf. Accessed 18 June 2009.
[17]
Berne GFS (2005) Sans-papiers en Suisse : c'est le marché de l'emploi qui est déterminant, non pas la politique d'asile. Bern. Available: http://www.bfm.admin.ch/etc/medialib/dat？a/migration/illegale_migration/sans_papi？ers.Par.0006.File.tmp/sans_papiers_studi？e.pdf. Accessed 18 June 2009.
[18]
Sztajzel J, Cox J, Pache JC, Badaoui E, Lerch R, et al. (1996) Chagas' disease may also be encountered in Europe. Eur Heart J 17: 1289. doi: 10.1093/oxfordjournals.eurheartj.a015048
[19]
Jackson Y, Chappuis F, Loutan L (2008) Chagas disease in Switzerland: managing an emerging infection and interrupting its transmission. Rev Med Suisse 4: 1212–4.6–7
[20]
Brazilian Ministerio do Salud (2005) Brazilian consensus on Chagas disease. Rev Soc Bras Med Trop 38: suppl 37–29.
[21]
de Rezende JLK, de Oliveira A (1960) Clinical and radiological aspects of aperistalsis of the esophagus. Rev Bras Gastroenterol 12: 247–62.
[22]
Steele LS, MacPherson DW, Kim J, Keystone JS, Gushulak BD (2007) The sero-prevalence of antibodies to trypanosoma cruzi in Latin American refugees and immigrants to Canada. J Immigr Minor Health 9: 43–7. doi: 10.1007/s10903-006-9014-x
[23]
Frank M, Hegenscheid B, Janitschke K, Weinke T (1997) Prevalence and epidemiological significance of Trypanosoma cruzi infection among Latin American immigrants in Berlin, Germany. Infection 25: 355–8. doi: 10.1007/BF01740817
[24]
Sosa-Estani S, Gamboa-Leon MR, Del Cid-Lemus J, Althabe F, Alger J, et al. (2008) Use of a rapid test on umbilical cord blood to screen for Trypanosoma cruzi infection in pregnant women in Argentina, Bolivia, Honduras, and Mexico. Am J Trop Med Hyg 79: 755–9.
[25]
Breniere SF, Bosseno MF, Noireau F, Yacsik N, Liegeard P, et al. (2002) Integrate study of a Bolivian population infected by Trypanosoma cruzi, the agent of Chagas disease. Mem Inst Oswaldo Cruz 97: 289–95. doi: 10.1590/S0074-02762002000300002
[26]
Senior K (2007) Chagas disease: moving towards global elimination. Lancet Infect Dis 7: 572. doi: 10.1016/S1473-3099(07)70194-9
[27]
Blum JA, Zellweger MJ, Burri C, Hatz C (2008) Cardiac involvement in African and American trypanosomiasis. Lancet Infect Dis 8: 631–41. doi: 10.1016/S1473-3099(08)70230-5
[28]
Kliewer E (1992) Epidemiology of diseases among migrants. Int Migr 30: 141–64. doi: 10.1111/j.1468-2435.1992.tb00781.x
[29]
Leiby DA, Herron RM Jr, Garratty G, Herwaldt BL (2008) Trypanosoma cruzi parasitemia in US blood donors with serologic evidence of infection. J Infect Dis 198: 609–13. doi: 10.1086/590159
[30]
Kun H, Moore A, Mascola L, Steurer F, Lawrence G, et al. (2009) Transmission of Trypanosoma cruzi by heart transplantation. Clin Infect Dis 48: 1534–40. doi: 10.1086/598931
